海通证券
Welcome to Haitong Securities!
简体中文| 繁體中文| English Customer Service Tel 95553
Official Account
Official Account
 Customer Service TOP
  • Home
  • About Haitong
  • Product & Service
  • Investor Relations
  • Haitong Group

    • Continued Success in the Pharmaceutical and Healthcare Industry - Haitong Empowers the Listing of Inventis Bio in the Growth Enterprise Market of the Shanghai Stock Exchange

    publication time：2022-07-25  from：海通证券

    On the 25th of July, Inventis Bio, for which Haitong is the deputy lead underwriter, successfully lists on the growth enterprise market of the Shanghai stock exchange, the first biomedical company to list under the fifth set of listing regulations.

    【close】
    海通证券

    Investment has certain risks, be wise with your decision

    China Securities Regulatory Commission Has Approved the Qualification of Haitong Securities for the Online Brokerage Service Copyright ©2003-2023 HAITONG Securities Company Limited All Rights Reserved